Population Genomic Screening and Improved Lipid Management in Patients With Familial Hypercholesterolemia

Following genetic screening, many patients with a pathogenic FH variant experienced improvements in clinical management and LDL-C levels. Electronic health record documentation of the diagnosis code was associated with a greater likelihood of therapeutic modifications, which, in turn, were associated with larger LDL-C reductions. Findings underscore the powerful potential of population genomic screening for supporting optimal lipid management in individuals with FH.

Authors

Institutions

Publication Details

Journal
Circulation Genomic and Precision Medicine
Published
2025-11-05
DOI
https://doi.org/10.1161/circgen.125.005206
Citations
1
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
2.01
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Population Genomic Screening and Improved Lipid Management in Patients With Familial Hypercholesterolemia

Natalie Telis, Chad Haldeman‐Englert, Douglas Stoller, Catherine Hajek et al.
1 citations
Circulation Genomic and Precision Medicine
Lipoproteins and Cardiovascular Health
2.01
article

Population Genomic Screening and Improved Lipid Management in Patients With Familial Hypercholesterolemia

Natalie Telis, Chad Haldeman‐Englert, Douglas Stoller, Catherine Hajek, Nicole Washington, Ashley Waring, Amy C. Sturm, Kelly M. Schiabor Barrett, Alexandre Bolze, Lisa M. McEwen, Matthew E. Levy, Joseph J. Grzymski, C. Anwar A. Chahal, David Kann, Elizabeth T. Cirulli, William Lee, Douglas A. Olson, Christopher N. Chapman, Megan Betts, Jeremy Cauwels, Basil Khuder
article en
1 citations

Abstract

Following genetic screening, many patients with a pathogenic FH variant experienced improvements in clinical management and LDL-C levels. Electronic health record documentation of the diagnosis code was associated with a greater likelihood of therapeutic modifications, which, in turn, were associated with larger LDL-C reductions. Findings underscore the powerful potential of population genomic screening for supporting optimal lipid management in individuals with FH.

Circulation Genomic and Precision MedicineVol. 18(6)
St. Luke's University Health Network (US), Sanford Health (US), Cone Health (US), University of Nevada, Reno (US), Medical University of South Carolina (US), The Ohio State University Wexner Medical Center (US), WellSpan Health (US), Helix (United States) (US), HealthPartners (US), University of Nebraska Medical Center (US)
Openalex Percentile: Top 10%
Lipoproteins and Cardiovascular Health
2.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.